A Study Of Galcanezumab In Participants With Episodic Cluster Headache
Clinical trial NCT02397473 · COMPLETED
Trial details
- NCT number
- NCT02397473
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-22
- Primary completion
- 2018-02-12
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.